SGLT-2 inhibitors are associated with lower rates of mortality following myocardial infarction in patients with type 2 diabetes - A SWEDEHEART observational study
Event:
ESC Congress 2023
Topic:
Pharmacotherapy
Session:
Pharmacotherapy in acute coronary syndromes